Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer

J.R. Kroep; S.C. Linn; E. Boven; H.J. Bloemendal; J. Baas; I.A.M. Mandjes; J.A. van den Bosch; W.M. Smit; H. de Graaf; C.P. Schroder; G.J. Vermeulen; W.C.J. Hop; J.W.R. Nortier

Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer

J.R. Kroep, S.C. Linn, E. Boven, H.J. Bloemendal, J. Baas, I.A.M. Mandjes, J.A. van den Bosch, W.M. Smit, H. de Graaf, C.P. Schroder, G.J. Vermeulen, W.C.J. Hop, J.W.R. Nortier

Medical oncology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	371-376
Journal	Netherlands journal of medicine
Volume	68
Issue number	9
Publication status	Published - 2010

Cite this

@article{8a54fdcd5d7546b0b9f3268c6b27618f,

title = "Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer",

author = "J.R. Kroep and S.C. Linn and E. Boven and H.J. Bloemendal and J. Baas and I.A.M. Mandjes and {van den Bosch}, J.A. and W.M. Smit and {de Graaf}, H. and C.P. Schroder and G.J. Vermeulen and W.C.J. Hop and J.W.R. Nortier",

year = "2010",

language = "Undefined/Unknown",

volume = "68",

pages = "371--376",

journal = "Netherlands journal of medicine",

issn = "0300-2977",

publisher = "Van Zuiden Communications BV",

number = "9",

}

TY - JOUR

T1 - Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer

AU - Kroep, J.R.

AU - Linn, S.C.

AU - Boven, E.

AU - Bloemendal, H.J.

AU - Baas, J.

AU - Mandjes, I.A.M.

AU - van den Bosch, J.A.

AU - Smit, W.M.

AU - de Graaf, H.

AU - Schroder, C.P.

AU - Vermeulen, G.J.

AU - Hop, W.C.J.

AU - Nortier, J.W.R.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0300-2977

VL - 68

SP - 371

EP - 376

JO - Netherlands journal of medicine

JF - Netherlands journal of medicine

IS - 9

ER -